Imagen de Portada

Preference for breast cancer screening in Chinese women: Discrete choice experiment

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Shuning Wu, Jianhao Du, Yifei Wang, Dawei Peng, Xinyang Ma, Jiali Chen, Jie Li, Gezi Li, Xing Li, Jun Zhang, Wai‐Kit Ming
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Cancer Medicine
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Initial ribociclib plus endocrine therapy for HR+/HER2− advanced breast cancer in pre‐ and postmenopausal Chinese women: Primary results from a phase 2 randomized study
por: Zhimin Shao, et al.
Publicado: (2024)

Trends in breast, colon, pancreatic, and uterine cancers in women during the COVID‐19 pandemic in North Carolina
por: Sarah J. Nyante, et al.
Publicado: (2024)

Omicron neutralization character in patients with breast cancer and liver cancer after the nationwide omicron outbreak
por: Shaohua Zhang, et al.
Publicado: (2024)

Opportunistic lung cancer screening with low‐dose computed tomography in National Cancer Center of China: The first 14 years' experience
por: Wei Tang, et al.
Publicado: (2024)

Factors associated with deferral or non‐performance of an organized breast cancer screening program during the COVID‐19 pandemic in France
por: Jean Papadacci Stephanopoli, et al.
Publicado: (2024)

Chemotherapy for post‐menopausal women with early breast cancer seems not to result in clinically significant changes in thyroid function
por: Djordje Marina, et al.
Publicado: (2024)

Correction to: Initial ribociclib plus endocrine therapy for HR+/HER2− advanced breast cancer in pre‐ and postmenopausal Chinese women: Primary results from a phase 2 randomized study
Publicado: (2024)

Effects of housing stability and contemporary mortgage lending bias on breast cancer stage at diagnosis among older women in the United States
por: Nicole Rademacher, et al.
Publicado: (2024)

Artificial intelligence in lung cancer screening: Detection, classification, prediction, and prognosis
por: Wu Quanyang, et al.
Publicado: (2024)

The efficiency and safety of low‐dose apatinib combined with oral vinorelbine in pretreated HER2‐negative metastatic breast cancer
por: Jia‐Yi Huang, et al.
Publicado: (2024)

Colorectal Cancer Screening Preferences of Recipients and Providers: A Dual‐Perspective Discrete Choice Experiment
por: Weimin Guan, et al.
Publicado: (2025)

PriorClinico‐RadiologicalFeatures InformedMulti‐Modal MRImages Convolution Neural Network: A novel deep learning framework for prediction of lymphovascular invasion in breast cancer
por: Hong Zheng, et al.
Publicado: (2024)

Genomic heterogeneity of multiple synchronous lung cancers in Chinese population
por: Lei Zhao, et al.
Publicado: (2024)

High glucose inhibits autophagy and promotes the proliferation and metastasis of colorectal cancer through the PI3K/AKT/mTOR pathway
por: Feng Li, et al.
Publicado: (2024)

Participant factors associated with psychosocial impacts of lung cancer screening: A systematic review
por: Kathleen McFadden, et al.
Publicado: (2024)

Reclassified the phenotypes of cancer types and construct a nomogram for predicting bone metastasis risk: A pan‐cancer analysis
por: Ming Li, et al.
Publicado: (2024)

Preservation of cfRNA in cytological supernatants for cfDNA & cfRNA double detection in non‐small cell lung cancer patients
por: Yidan Ma, et al.
Publicado: (2024)

Examining inequities associated with incarceration among breast cancer patients
por: Yoshiko Iwai, et al.
Publicado: (2024)

Pathological and clinical outcomes following neoadjuvant dual HER2 therapy for early‐stage breast cancer: An Australian institutional real‐world experience
por: Sathya Narayanan, et al.
Publicado: (2024)

Nomograms for predicting recurrence of HER2‐positive breast cancer with different HR status based on ultrasound and clinicopathological characteristics
por: Xudong Zhang, et al.
Publicado: (2024)

Prognostic implications of HER2NEU‐low in metastatic breast cancer
por: Zachary Neubauer, et al.
Publicado: (2024)

Emerging roles of tripartite motif family proteins (TRIMs) in breast cancer
por: Jianing Cao, et al.
Publicado: (2024)

Relationship between fear of progression and symptom burden, disease factors and social/family factors in patients with stage‐IV breast cancer in Shandong, China
por: Qianrun Lu, et al.
Publicado: (2024)

Mitochondrial dynamics as a novel treatment strategy for triple‐negative breast cancer
por: Yuechen Wang, et al.
Publicado: (2024)

Associations of brain‐derived neurotrophic factor rs6265 polymorphism and cognitive function in breast cancer survivors from a cross‐sectional study
por: Taichi Goto, et al.
Publicado: (2024)

BMI ‐dependent prognostic role of EEF1G in breast cancer: A 15‐year follow‐up of the Guangzhou Breast Cancer Cohort Study
por: Na Li, et al.
Publicado: (2025)

Fear of cancer recurrence in breast cancer survivors carrying a BRCA1/2 mutation: A qualitative study
por: Josée Savard, et al.
Publicado: (2024)

A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer
por: Jana Soukupova, et al.
Publicado: (2024)

Ultrahypofractionation in postoperative radiotherapy for breast cancer: A single‐institution retrospective cohort series
por: Angel Calvo Tudela, et al.
Publicado: (2024)

Clinical relevance of somatic mutations in Chinese lung adenocarcinoma and their prognostic implications for survival
por: Tongxin Li, et al.
Publicado: (2024)

Examining the role of pre‐visit anxiety on patient uncertainty and breast cancer patient–provider communication
por: Elizabeth A. Broadbridge, et al.
Publicado: (2024)

Causal associations between atrial fibrillation and breast cancer: A bidirectional Mendelian randomization analysis
por: Zhaoting Gong, et al.
Publicado: (2024)

County‐level colorectal cancer screening rates on colorectal cancer survival in the state of Georgia: Does county‐level rurality matter?
por: Meng‐Han Tsai, et al.
Publicado: (2024)

Reinforcement learning for individualized lung cancer screening schedules: A nested case–control study
por: Zixing Wang, et al.
Publicado: (2024)

A highly sensitive screening system to evaluate the reversibility of neuroendocrine prostate cancer to prostate adenocarcinoma
por: Tomohiro Fukui, et al.
Publicado: (2025)

Health insurance as a moderator in the relationship between financial toxicity and medical cost‐coping behaviors: Evidence from patients with lung cancer in China
por: Yongchun Cui, et al.
Publicado: (2024)

Neoadjuvant chemotherapy for breast cancer: Pathologic response rates but not tumor size, has an independent prognostic impact on survival
por: Gilles Houvenaeghel, et al.
Publicado: (2024)

Efficacy and safety of eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with anthracycline/taxanes
por: Lan Chen, et al.
Publicado: (2024)

Are embryonic stem cell markers and ALDH1A1 relevant in the context of breast cancer estrogen positivity?
por: Noha A. Mousa, et al.
Publicado: (2024)

Bone mineral density fall during aromatase inhibitor treatment may predict lower breast cancer recurrence
por: Hilary Martin, et al.
Publicado: (2024)